Furthermore, strengthening the SphK1–S1P–S1PR1 axis in combination with GC application might become a novel strategy for ALI therapy, and thereby enhance the efficacy of short-range GC treatment in septic patients since 40% of them develop ALI. This evidence concerns the gene S1PR1 and acute respiratory distress syndrome.